Global equity markets came under sharp selling pressure on Tuesday as a broad risk-off mood gripped investors, dragging major US indices sharply lower while European markets, including the UK’s FTSE 100, closed in the red.
In the US, the S&P 500 fell 2.06% to 6,796.86, while the Nasdaq Composite plunged 2.39% to 22,954.32, led by heavy losses in large-cap technology stocks. The Dow Jones Industrial Average dropped 870.74 points, or 1.76%, to 48,488.59.
Market volatility spiked, with the CBOE Volatility Index (VIX) jumping 6.63% to 20.09, reflecting growing investor nervousness.
Big Tech, ETFs See Heavy Selling
Among the most actively traded stocks by dollar volume:
Nvidia (NVDA) slid 4.38%
Tesla (TSLA) declined 4.17%
Apple (AAPL) fell 3.46%
SPDR S&P 500 ETF (SPY) dropped 2.04%
Invesco QQQ Trust (QQQ) lost 2.12%
By share volume, Nvidia, ImmunityBio (IBRX) and INVO Fertility (IVF) remained among the most traded counters, reflecting heightened churn across sectors.
Sharp Stock-Level Moves
In US trading, select stocks saw extreme moves:
INVO Fertility (IVF) surged over 191%
Corvus Pharmaceuticals (CRVS) jumped 166%
Lavoro Ltd (LVROW) gained nearly 99%
On the downside:
NovaBay Pharmaceuticals (NBY) crashed over 55%
Synlogic (SYBX) fell 50%
Dermata Therapeutics (DRMAW) dropped 48%
European Markets Track Wall Street Lower
European equities mirrored the weak global sentiment:
FTSE 100 closed 0.67% lower at 10,126.78
Germany’s DAX fell 1.03%
France’s CAC 40 slipped 0.61%
EURO STOXX 50 eased 0.57%
Despite the broader decline, select UK stocks advanced, with Informa PLC, Haleon, Endeavour Mining, Rentokil Initial, Melrose Industries, Coca-Cola Europacific Partners, Rolls-Royce Holdings, and NatWest Group featuring among the FTSE 100 gainers.
Market View
Analysts attribute the synchronized global sell-off to rising uncertainty around growth and valuations, particularly in technology-heavy indices. With volatility rising and liquidity concentrated in mega-cap stocks, markets are expected to remain sensitive to macro data and earnings cues in the near term.
